MT Newswires
Viatris, Opus Genetics Say US FDA Agrees to Review New Drug Application for Potential Eye Condition Treatment
➖
AI Sentiment
Neutral
5/10
Latest updates and market news for VTRS
AI Sentiment
Neutral
5/10
AI Sentiment
Highly Positive
8/10
AI Sentiment
Positive
7/10
AI Sentiment
Positive
7/10
AI Sentiment
Neutral
4/10
AI Sentiment
Negative
3/10
Share this news page